Title : BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis.

Pub. Date : 2015 Dec

PMID : 26438154






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We describe here the profile of the novel compound BI 885578, a potent and selective ATP-competitive IGF1R/INSR tyrosine kinase inhibitor distinguished by rapid intestinal absorption and a short in vivo half-life as a result of rapid metabolic clearance. Adenosine Triphosphate insulin receptor Homo sapiens